Abraham WT - Search Results

1

Rationale and design of a randomized clinical trial to assess the safety and efficacy of frequent optimization of cardiac resynchronization therapy: the Frequent Optimization Study Using the QuickOpt Method (FREEDOM) trial.

Abraham WT, Gras D, Yu CM, Guzzo L, Gupta MS; FREEDOM Steering Committee. Abraham WT, et al. Am Heart J. 2010 Jun;159(6):944-948.e1. doi: 10.1016/j.ahj.2010.02.034. Am Heart J. 2010. PMID: 20569704 Review.

2

Electrophysiological aids in congestive heart failure: supporting and synchronizing systole.

Abraham WT. Abraham WT. Med Clin North Am. 2003 Mar;87(2):509-21. doi: 10.1016/s0025-7125(02)00180-3. Med Clin North Am. 2003. PMID: 12693737 Review.

3

Cardiac resynchronization therapy: a review of clinical trials and criteria for identifying the appropriate patient.

Abraham WT. Abraham WT. Rev Cardiovasc Med. 2003;4 Suppl 2:S30-7. Rev Cardiovasc Med. 2003. PMID: 12776011 Review.

4

Cardiac resynchronization therapy for heart failure.

Abraham WT, Hayes DL. Abraham WT, et al. Circulation. 2003 Nov 25;108(21):2596-603. doi: 10.1161/01.CIR.0000096580.26969.9A. Circulation. 2003. PMID: 14638522 Review. No abstract available.

5

Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design.

Fonarow GC, Abraham WT, Albert NM, Gattis WA, Gheorghiade M, Greenberg B, O'Connor CM, Yancy CW, Young J. Fonarow GC, et al. Among authors: abraham wt. Am Heart J. 2004 Jul;148(1):43-51. doi: 10.1016/j.ahj.2004.03.004. Am Heart J. 2004. PMID: 15215791

6

Cardiac resynchronization therapy for the management of chronic heart failure.

Abraham WT. Abraham WT. Am Heart Hosp J. 2003 Winter;1(1):55-61. doi: 10.1111/j.1541-9215.2003.02079.x. Am Heart Hosp J. 2003. PMID: 15785177 Review.

7

Predictors of response to cardiac resynchronization therapy (PROSPECT)--study design.

Yu CM, Abraham WT, Bax J, Chung E, Fedewa M, Ghio S, Leclercq C, León AR, Merlino J, Nihoyannopoulos P, Notabartolo D, Sun JP, Tavazzi L; PROSPECT Investigators. Yu CM, et al. Among authors: abraham wt. Am Heart J. 2005 Apr;149(4):600-5. doi: 10.1016/j.ahj.2004.12.013. Am Heart J. 2005. PMID: 15990740

8

Rationale and design of a randomized controlled trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with asymptomatic left ventricular dysfunction with previous symptoms or mild heart failure--the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.

Linde C, Gold M, Abraham WT, Daubert JC; REVERSE Study Group. Linde C, et al. Among authors: abraham wt. Am Heart J. 2006 Feb;151(2):288-94. doi: 10.1016/j.ahj.2005.03.002. Am Heart J. 2006. PMID: 16442890

9

Cardiac resynchronization therapy.

Abraham WT. Abraham WT. Prog Cardiovasc Dis. 2006 Jan-Feb;48(4):232-8. doi: 10.1016/j.pcad.2005.11.001. Prog Cardiovasc Dis. 2006. PMID: 16517245 Review.

10

Clinical predictors and timing of New York Heart Association class improvement with cardiac resynchronization therapy in patients with advanced chronic heart failure: results from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) and Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE-ICD) trials.

Pires LA, Abraham WT, Young JB, Johnson KM; MIRACLE and MIRACLE-ICD Investigators. Pires LA, et al. Among authors: abraham wt. Am Heart J. 2006 Apr;151(4):837-43. doi: 10.1016/j.ahj.2005.06.024. Am Heart J. 2006. PMID: 16569543

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

622 results

Search Page

Filters